1 Min Read
March 7 (Reuters) - Valeant Pharmaceuticals International Inc
* Valeant commences cash tender offer for up to $600,000,000 outstanding principal amount of its 6.75 pct senior notes due 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.